Biosimilars-2012 is a remarkable event which brings together a unique and International mix of large and medium Pharmaceutical and Biotech companies; leading universities and Pharmacological research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging technologies across the globe. Conference Highlights: 1.Biosimilars: Innovator pharmaceutical products 2.Commercialization or globalization of Biosimilars 3.Skill Set for Biosimilars development 4.Biosimilars: Regulatory Approach 5.Biosimilars Monoclonal Antibodies 6.Biosimilars Therapeutics 7.Biowaivers: Regulatory Approach 8.Types of biowaivers 9.Bioequivalence assessment 10.Biowaivers 11.Biowaiver Monographs 12.Biowaivers: Practical applications Dates: 10-12 September 2012 Venue: San Antonio, TX, USA Important Dates: Abstract Submission Opens: 21 November 2011 Registration Opens: 28 November 2011 First Round of Abstract Submission: 15 February 2012 Early bird Registration: 03 March 2012 Second Round of Abstract Submission: 10 June 2012 Last date for Registration: 13 April 2012 Deadline for Abstract Submission: 20 July 2012 Deadline for Registration: 29 July 2012 On spot Registration: 10 September 2012 Who should attend? Legal affairs, principal scientists, chief scientific officers, regulatory affairs, Healthcare agencies, Pharmacovigilance, Directors, Deans and Managers from follow-on-Biologic, Health economics, Bio-pharmaceuticals, Drug safety and risk management, Research and Development and commercial affairs. For registration: http://www.omicsonline.org/biosimilars2012/registration.php Submit Your Abstract Online at: http://omicsonline.org/biosimilars2012/abstract.php